Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ACADIA Pharmaceuticals Company Profile (NASDAQ:ACAD)

Consensus Ratings for ACADIA Pharmaceuticals (NASDAQ:ACAD) (?)
Ratings Breakdown: 3 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $27.33 (32.56% upside)

Analysts' Ratings History for ACADIA Pharmaceuticals (NASDAQ:ACAD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/15/2014Morgan JosephInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
5/15/2014JPMorgan Chase & Co.Initiated CoverageOverweight$33.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Jefferies GroupBoost Price Target$26.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2014ZacksDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
1/22/2014ZacksReiterated RatingOutperform -> Outperform$26.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2013Ned Davis ResearchInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
8/8/2013Roth CapitalBoost Price TargetBuy$20.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013ZacksReiterated RatingOutperform -> Outperform$26.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013Ladenburg ThalmannBoost Price TargetBuy$15.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013Needham & Company LLCBoost Price TargetBuy$16.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013MLV & Co DowngradeBuy -> Hold$18.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
6/14/2013JMP SecuritiesBoost Price TargetBuy$16.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2013Needham & Company LLCReiterated RatingBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2013Jefferies GroupReiterated RatingBuy -> Positive$18.00ViewTweet This Rating  Share This Rating on StockTwits
4/12/2013JMP SecuritiesBoost Price TargetMarket Outperform$9.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
4/12/2013Jefferies GroupBoost Price TargetBuy$13.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2013MLV & Co Boost Price TargetBuy$12.50 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2013Roth CapitalBoost Price TargetBuy$15.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2013Piper JaffrayUpgradeNeutral -> OverweightViewTweet This Rating  Share This Rating on StockTwits
4/11/2013Needham & Company LLCBoost Price TargetBuy$9.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2013Ladenburg ThalmannBoost Price TargetBuy$9.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
3/28/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/25/2013Roth CapitalBoost Price TargetBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
3/25/2013Jefferies GroupReiterated RatingBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013Jefferies GroupInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013Jefferies GroupInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2013Jefferies GroupInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
3/13/2013Ladenburg ThalmannBoost Price TargetBuy$8.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2013Cantor FitzgeraldInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
1/28/2013Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Piper JaffrayInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
11/28/2012MLV & Co Boost Price TargetBuy$4.50 -> $8.50ViewTweet This Rating  Share This Rating on StockTwits
11/27/2012Ladenburg ThalmannReiterated RatingBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
11/27/2012Needham & Company LLCUpgradeHold -> Buy$9.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2012 forward)